Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAMELA B BAINES

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1750378170
CMS profile
306445
Location
TAMPA, FL

General Payments · PY2018–2024

$7,281.66

  • Reported across 274 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,545.98

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,451.35 53
Education $94.63 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $515.33 13
GENZYME CORPORATION $379.41 13
OptiNose US, Inc. $191.49 11
Pharming Healthcare, Inc. $150.43 1
GlaxoSmithKline, LLC. $131.16 7
Acerta Pharma LLC $58.46 3
Phadia US Inc. $53.61 3
Amgen Inc. $32.47 1
Checkpoint Surgical, Inc $18.74 1
ConvaTec Inc. $14.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $876.72 37
PY2019 $1,641.62 49
PY2020 $396.86 21
PY2021 $403.82 20
PY2022 $1,421.05 57
PY2023 $995.61 36
PY2024 $1,545.98 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $32.47 02/01/2024 Food and Beverage Undisputed 01/23/2026 1117499704 CMS
AstraZeneca Pharmaceuticals LP $24.05 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105811419 CMS
AstraZeneca Pharmaceuticals LP $14.55 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105594285 CMS
AstraZeneca Pharmaceuticals LP $19.86 10/28/2024 Food and Beverage Undisputed 01/23/2026 1104502922 CMS
Checkpoint Surgical, Inc $18.74 11/12/2024 Food and Beverage Undisputed 01/23/2026 1143873655 CMS
ConvaTec Inc. $14.88 08/08/2024 Food and Beverage Undisputed 01/23/2026 1151370329 CMS
GENZYME CORPORATION $30.41 01/04/2024 Food and Beverage Undisputed 01/23/2026 1139592598 CMS
GENZYME CORPORATION $29.57 02/15/2024 Food and Beverage Undisputed 01/23/2026 1139592608 CMS
GENZYME CORPORATION $28.46 03/28/2024 Food and Beverage Undisputed 01/23/2026 1139592626 CMS
GENZYME CORPORATION $21.46 04/18/2024 Food and Beverage Undisputed 01/23/2026 1139592664 CMS
GENZYME CORPORATION $26.82 06/06/2024 Food and Beverage Undisputed 01/23/2026 1139592666 CMS
GENZYME CORPORATION $35.53 06/27/2024 Food and Beverage Undisputed 01/23/2026 1139592672 CMS
GENZYME CORPORATION $25.88 07/02/2024 Food and Beverage Undisputed 01/23/2026 1139592678 CMS
GENZYME CORPORATION $36.42 07/18/2024 Food and Beverage Undisputed 01/23/2026 1139592690 CMS
GENZYME CORPORATION $28.26 08/23/2024 Food and Beverage Undisputed 01/23/2026 1139592708 CMS
GENZYME CORPORATION $29.66 09/12/2024 Food and Beverage Undisputed 01/23/2026 1139592714 CMS
GENZYME CORPORATION $28.96 10/24/2024 Food and Beverage Undisputed 01/23/2026 1139592752 CMS
GENZYME CORPORATION $28.57 11/14/2024 Food and Beverage Undisputed 01/23/2026 1139592736 CMS
GENZYME CORPORATION $29.41 12/19/2024 Food and Beverage Undisputed 01/23/2026 1139592744 CMS
GlaxoSmithKline, LLC. $20.20 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116579348 CMS
GlaxoSmithKline, LLC. $19.29 07/01/2024 Food and Beverage Undisputed 01/23/2026 1116260909 CMS
GlaxoSmithKline, LLC. $20.02 07/10/2024 Food and Beverage Undisputed 01/23/2026 1116354397 CMS
GlaxoSmithKline, LLC. $18.34 09/17/2024 Food and Beverage Undisputed 01/23/2026 1116301620 CMS
GlaxoSmithKline, LLC. $20.71 09/18/2024 Food and Beverage Undisputed 01/23/2026 1116295407 CMS
GlaxoSmithKline, LLC. $4.54 10/04/2024 Food and Beverage Undisputed 01/23/2026 1116421041 CMS
GlaxoSmithKline, LLC. $28.06 12/11/2024 Food and Beverage Undisputed 01/23/2026 1116219725 CMS
Optinose US, Inc. $17.99 01/11/2024 Food and Beverage Undisputed 01/23/2026 1142172812 CMS
Optinose US, Inc. $16.47 02/21/2024 Food and Beverage Undisputed 01/23/2026 1142172834 CMS
Optinose US, Inc. $28.17 03/05/2024 Food and Beverage Undisputed 01/23/2026 1142172858 CMS
Optinose US, Inc. $15.46 05/03/2024 Food and Beverage Undisputed 01/23/2026 1142172876 CMS
Optinose US, Inc. $15.05 05/16/2024 Food and Beverage Undisputed 01/23/2026 1142172874 CMS
Optinose US, Inc. $5.63 05/30/2024 Food and Beverage Undisputed 01/23/2026 1142172868 CMS
Optinose US, Inc. $9.39 07/26/2024 Food and Beverage Undisputed 01/23/2026 1142172908 CMS
Optinose US, Inc. $19.60 08/09/2024 Food and Beverage Undisputed 01/23/2026 1142172936 CMS
Optinose US, Inc. $18.59 10/18/2024 Food and Beverage Undisputed 01/23/2026 1142172932 CMS
Optinose US, Inc. $26.14 12/02/2024 Food and Beverage Undisputed 01/23/2026 1142172946 CMS
Optinose US, Inc. $19.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1142172952 CMS
Phadia US Inc. $14.95 01/11/2024 Food and Beverage Undisputed 01/23/2026 1067584632 CMS
Phadia US Inc. $21.85 04/17/2024 Food and Beverage Undisputed 01/23/2026 1067584634 CMS
Phadia US Inc. $16.81 10/31/2024 Food and Beverage Undisputed 01/23/2026 1067584636 CMS
Pharming Healthcare, Inc. $150.43 12/03/2024 Food and Beverage Undisputed 01/23/2026 1132142558 CMS
Regeneron Healthcare Solutions, Inc. $116.91 01/27/2024 Food and Beverage Undisputed 01/23/2026 1114003685 CMS
Regeneron Healthcare Solutions, Inc. $26.91 02/09/2024 Food and Beverage Undisputed 01/23/2026 1114003687 CMS
Regeneron Healthcare Solutions, Inc. $5.06 04/04/2024 Food and Beverage Undisputed 01/23/2026 1114003689 CMS
Regeneron Healthcare Solutions, Inc. $28.76 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114003691 CMS
Regeneron Healthcare Solutions, Inc. $1.16 04/08/2024 Food and Beverage Undisputed 01/23/2026 1114003693 CMS
Regeneron Healthcare Solutions, Inc. $33.38 04/09/2024 Food and Beverage Undisputed 01/23/2026 1114003695 CMS
Regeneron Healthcare Solutions, Inc. $26.62 05/10/2024 Food and Beverage Undisputed 01/23/2026 1114003697 CMS
Regeneron Healthcare Solutions, Inc. $23.96 08/05/2024 Food and Beverage Undisputed 01/23/2026 1114003699 CMS
Regeneron Healthcare Solutions, Inc. $94.63 08/06/2024 Education Undisputed 01/23/2026 1114003701 CMS
Regeneron Healthcare Solutions, Inc. $87.06 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114003703 CMS
Regeneron Healthcare Solutions, Inc. $26.34 10/29/2024 Food and Beverage Undisputed 01/23/2026 1114003705 CMS
Regeneron Healthcare Solutions, Inc. $17.09 10/31/2024 Food and Beverage Undisputed 01/23/2026 1114003707 CMS
Regeneron Healthcare Solutions, Inc. $27.45 12/17/2024 Food and Beverage Undisputed 01/23/2026 1114003709 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.